Key facts Oral diseases, while largely preventable, pose a major health burden for many countries…
Continue ReadingTag: oral
Chart review supports expansion of subcutaneous immunotherapy, oral food challenges
March 03, 2025 4 min read Add topic to email alerts …
Continue Reading
Omalizumab treats multi-food allergy better than oral immunotherapy
News Release Monday, March 3, 2025 High rate of oral immunotherapy side effects in NIH…
Continue Reading
Omalizumab outperforms oral immunotherapy in treating multi-food allergy
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more…
Continue Reading